SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Panasonic Advanced Technologys announcement of a working Jasmy/JANCTION Smart Render product is driving attention, with traders highlighting distributed-GPU rendering and potential commercial use. Many are bullish on the development and recent price action, while others question whether the collaboration will create direct demand for JASMY tokens.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns upcoming earnings report and forward guidance are the main focus, with traders watching whether AI-driven HBM and DRAM demand can sustain tight supply and elevated margins. Bulls expect strong results to support further gains, while skeptics argue expectations are already high and debate whether the stock could sell off after the report.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuums finalized federal CHIPS R&D award is drawing attention as a sign of U.S. government backing for its quantum-computing and manufacturing efforts. Traders are reacting positively to the support, while skeptics point to the companys high valuation, limited revenue and volatile trading.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin has rallied with a broader crypto-market rebound, drawing bullish attention to its attempt to break above a key resistance level. Traders are divided between expecting the momentum to continue and warning that the move may fade if the breakout fails.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is drawing attention for volatile silver trading and a choppy pullback after a sharp run-up, with traders debating whether support is forming or further weakness lies ahead. Bulls cite inflation, currency-debasement concerns, and tight silver supply, while others point to rising yields and a stronger dollar as headwinds.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on Capricors planned World Muscle Society presentation of 24-month HOPE-3 extension data for deramiocel, which traders see as a key catalyst ahead of the FDAs review of the DMD therapy. Bulls expect the longer-term results to support efficacy, while skeptics question the statistical analysis and stress that positive data would not guarantee approval.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCIs rally is being tied to Supermicros AI-server and cooling-system role in SpaceX/xAIs expanding data-center plans, amplified by CEO Charles Liangs post teasing a year-end surprise; traders speculate it signals further orders, while confirmed Vera Rubin rack shipments add to the AI-infrastructure narrative. The reaction is largely bullish and focused on a technical breakout, though some traders question whether the SpaceX speculation is being overstated and remain wary of dilution and management-related risks.

Aventus Network

A sharp AVT rebound has sparked breakout chatter, with traders pointing to its low float and thin order books as factors that could amplify price swings. Optimism about a continued move is tempered by concerns that the hype is bot-driven and that the gains may not hold without sustained volume.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Middle East supply risks, especially uncertainty around reopening the Strait of Hormuz, are keeping crude prices and energy stocks in focus. Traders see higher oil as supportive for Chevron, though some question why CVX has not consistently followed crude higher; the companys Venezuela expansion and broader exploration plans also feature in the discussion.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

ONDOs rally is drawing attention to Ondos role in tokenized real-world assets and institutional ties, especially BlackRock-related portfolio products and integrations. Bulls see growing RWA adoption as a tailwind, while others question whether that growth benefits ONDO holders without a fee switch or other value-accrual mechanism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Options Traders Betting on a Big Move in Journey Medical Stock?

Investors need to pay close attention to DERM stock based on the movements in the options market lately.

ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?

Elite Pharmaceuticals and Journey Medical follow different growth paths, but which looks more compelling now? Let's dive in.

Journey Medical (DERM) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings

The headline numbers for Journey Medical (DERM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates

Journey Medical (DERM) delivered earnings and revenue surprises of 0.00% and -1.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -50.00% and -11.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ardelyx (ARDX) Reports Q2 Loss, Lags Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of -40.00% and -2.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock?

Merck KGaA (MKKGY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings

The headline numbers for Journey Medical (DERM) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates

Journey Medical (DERM) delivered earnings and revenue surprises of -14.29% and +5.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Journey Medical Corporation is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$6.14
Prev Close	$6.32
Open	$6.38
Dividend Yield	0.00%
50-Day Moving Average	$6.98
Beta	1.06
Avg. Volume	226,329.45
PE Ratio	-26.50

52-Week High	$9.56
52-Week Low	$4.31
Market Capitalization	$173.3M
EPS (Annual)	-$0.4666
Price to Book	5.29
Revenue Per Employee	$1.07M

Feed

News

Sentiment

Earnings

Fundamentals

Info

DERM Fundamentals